Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Pareto Securities AB and Swedbank AB (publ) in connection with a bond issue with a framework amount of up to MSEK 700
Mandate

Vinge has advised Pareto Securities AB and Swedbank AB (publ) in connection with a bond issue with a framework amount of up to MSEK 700

December 18, 2017 Banking and Finance

Vinge has advised Pareto Securities AB and Swedbank AB (publ) in connection with a bond issue with a framework amount of up to MSEK 700 senior unsecured floating rate bonds, issued by Offentliga Hus i Norden AB (publ) (”Offentliga Hus”) on 15 December 2017.

Pareto Securities AB and Swedbank AB (publ) have acted as arrangers and Swedbank AB (publ) also acted as issuing agent. The bonds have a tenor of three and a half years and a floating interest rate of three-months STIBOR plus a margin of 7.00 per cent.
 
The proceeds from the bond issue will be applied towards financing property acquisitions and other general corporate purposes. Offentliga Hus intends to apply for the bonds to be listed on Nasdaq Stockholm.
 
Vinges team consisted inter alia of Louise Brorsson Salomon, Lionardo Ojeda and Sara Osman.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026